Cancer Clinical Trials Act

“When patients are denied access to cancer clinical trials, we lose our best hope of curing cancer. As a physician and researcher, I’ve seen firsthand patients who receive the latest treatments and live. And, I’ve also seen those patients - who are denied access to those same discoveries - lose their fight against the disease.”

Michael Caligiuri, MD
Director, Comprehensive Cancer Center
CEO, James Cancer Hospital and Solove Research Institute
J.L. Marakas Nationwide Insurance Enterprise Foundation Chair in Cancer Research
The Ohio State University

Cancer Clinical Trials Act

Listen to Sheryl Freeman's plea to help patients like her by supporting better access to cancer clinical trials.

FireFox users need the most recent version of the Windows Media Player for Firefox plugin.

In April 2008, at the urging of The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, the Ohio General Assembly introduced and passed legislation requiring Ohio-based, fully-funded insurance companies to pay the routine care costs for cancer patients enrolled in clinical trials. The law went into effect Oct. 4, 2008, as one of the strongest statutes in the country to date.

When President Obama signed the Patient Protection and Affordable Care Act into law on March 23, 2010, it included a provision introduced by U.S. Senator Sherrod Brown (D-OH) announced legislation that would protect access to treatment options for patients diagnosed with cancer. Brown’s amendment prevents insurance companies from denying patients participating in clinical trials coverage for the services they would otherwise receive under their healthcare plans. The provision will go into effect in 2014.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu